
Amylyx Pharmaceuticals, Inc.
USD18.50
+1.05 (+6.02%)
CEO
Joshua Cohen
IPO Date
2022-01-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.88
Prev. Close
$17.45
Day Low
$17.88
Day High
$18.86
52W Low
$7.48
52W High
$19.15
Market Cap
$1.54B
Volume
2.67M
| 25 Mar 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 19 Mar 2026 | Guggenheim | Buy | Buy | maintain |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Feb 2026 | B of A Securities | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 7 Nov 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Oct 2025 | Citigroup | Buy | Buy | maintain |